- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 13 - Healthcare Reform's Impact on Immunotherapy (Part 2)
As the panelists continue discussing how healthcare reform will affect cancer therapy, the experts believe that although cost of therapy is a concern when treating patients, it does not form the entire equation that should be used when considering a treatment plan. Cost is an additional factor that should be assessed when determining value.
Daniel J. George, MD, explains that when determining the value of a treatment option, such as immunotherapy, medical professionals need to use an equation of quality over cost.
Unfortunately, Dr George fears that practitioners may feel that utilizing more expensive therapies due to improved outlooks on quality for their patients may cause practitioners to feel as though they are being penalized. Under this new model, it is important that medical professionals understand that the lowest cost should not be a deciding factor when considering immunotherapy treatment.
Oncologists will need to become comfortable with this new model, explains Michael Kolodziej, MD. In addition to reviewing data, oncologists will need to practice transparency, fairness, shared decision making, and consumerism, which are all factors that will affect the results of the new healthcare system.
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
